Bone-headed decision of Astrazeneca to not be transparent with American public: Chris Meekins

Len Yaffe, Stoc*Doc Partners managing director, and Chris Meekins, Raymond James, joins 'Closing Bell' to discuss the halt of Astrazeneca's vaccine trial and whether they were disturbed by the decision of the company to selectively disclose the information to certain investors.